Attention iRhythm Technologies, Inc. (IRTC) Shareholders: Grabar Law Office Investigates Claims on Your Behalf

Philadelphia, Pennsylvania--(Newsfile Corp. - April 12, 2024) - Grabar Law Office is investigating whether the Board of Directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) ("iRhythm") breached their fiduciary duties to shareholders.

If you have held iRhythm shares since prior to January 11, 2022, learn more at https://grabarlaw.com/the-latest/irhythm-shareholder-investigation/, or call Joshua H. Grabar at 267-507-6085.

WHY: A recently filed securities fraud class action complaint alleges that iRhythm Technologies, Inc. (NASDAQ: IRTC), via certain of its officers and directors, falsely represented to investors that the Zio AT monitor was a real-time monitor intended for high-risk patients. Specifically, the complaint alleges that Defendants repeatedly touted the potential growth for the Zio AT as an innovative product that had only just begun to penetrate the market for real-time monitoring, which investors looked upon favorably given the premium selling price associated with devices approved for high-risk patients. As a result of these misrepresentations, it is alleged that the price of iRhythm common stock traded at artificially inflated prices.

WHAT TO DO NOW: Current iRhythm shareholders who have held iRhythm shares since prior to January 11, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/irhythm-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, Mia R. Heller at mheller@grabarlaw.com, or call us at 267-507-6085.

Attorney Advertising Disclaimer

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/205284